Cargando…

VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors

BACKGROUND: As a proteoglycan, VCAN exists in the tumor microenvironment and regulates tumor proliferation, invasion, and metastasis, but its role in hepatocellular carcinoma (HCC) has not yet been elucidated. AIM: To investigate the expression and potential mechanism of action of VCAN in HCC. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mu-Qi, Li, Ya-Ping, Xu, Meng, Tian, Yan, Wu, Yuan, Zhang, Xin, Shi, Juan-Juan, Dang, Shuang-Suo, Jia, Xiao-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611428/ https://www.ncbi.nlm.nih.gov/pubmed/36310697 http://dx.doi.org/10.4251/wjgo.v14.i10.1933

Ejemplares similares

Caffeic acid phenethyl ester up-regulates antioxidant levels in hepatic stellate cell line T6 via an Nrf2-mediated mitogen activated protein kinases pathway
por: Yang, Ning, et al.
Publicado: (2017)

Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma
por: Wei, Xiao-Cui, et al.
Publicado: (2021)

Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Immunological classification of hepatitis B virus-positive hepatocellular carcinoma by transcriptome analysis
por: Li, Sheng-Wei, et al.
Publicado: (2022)

Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets
por: Huang, Zi-Lin, et al.
Publicado: (2019)

Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma
por: Zhao, Hui-Qi, et al.
Publicado: (2020)

Association between polymorphisms of the APOBEC3G gene and chronic hepatitis B viral infection and hepatitis B virus-related hepatocellular carcinoma
por: He, Xiu-Ting, et al.
Publicado: (2017)

Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients
por: Yao, Qun-Yan, et al.
Publicado: (2020)

Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients
por: Fasullo, Matthew, et al.
Publicado: (2019)

Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-β/Smad signaling pathway
por: Zou, Gao-Liang, et al.
Publicado: (2019)

Potential microRNA panel for the diagnosis and prediction of overall survival of hepatocellular carcinoma with hepatitis B virus infection
por: Zhang, Qi, et al.
Publicado: (2020)

Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis
por: Iyer, Janaki K, et al.
Publicado: (2017)

Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China
por: Yang, Ying, et al.
Publicado: (2019)

Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study
por: Wu, Feng-Ping, et al.
Publicado: (2020)

Lycopene modulates cellular proliferation, glycolysis and hepatic ultrastructure during hepatocellular carcinoma
por: Gupta, Prachi, et al.
Publicado: (2016)

Identification of candidate biomarkers correlated with pathogenesis of postoperative peritoneal adhesion by using microarray analysis
por: Bian, Yao-Yao, et al.
Publicado: (2020)

Molecular mechanisms of apoptosis in hepatocellular carcinoma cells induced by ethanol extracts of Solanum lyratum Thumb through the mitochondrial pathway
por: Mo, Xiao-Qiang, et al.
Publicado: (2017)

Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis via inducing cell cycle arrest and apoptosis
por: Guo, Jian, et al.
Publicado: (2019)

Role and mechanism of circ-PRKCI in hepatocellular carcinoma
por: Qi, Su-Xia, et al.
Publicado: (2019)

Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B
por: Wang, Xuyang, et al.
Publicado: (2017)

Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells
por: Han, Qiu-Ju, et al.
Publicado: (2021)

Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis
por: Yuan, Mengqin, et al.
Publicado: (2022)

Immune response pattern varies with the natural history of chronic hepatitis B
por: Wang, Wen-Tao, et al.
Publicado: (2019)

Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer
por: Zhu, Xiao-Liang, et al.
Publicado: (2019)

Increased ATG5-ATG12 in hepatitis B virus-associated hepatocellular carcinoma and their role in apoptosis
por: Kunanopparat, Areerat, et al.
Publicado: (2016)

Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma
por: Sheng, Qiu-Ju, et al.
Publicado: (2020)

Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells in vivo and in vitro by activating AMP-activated protein kinase
por: Li, Zhen, et al.
Publicado: (2018)

Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C
por: Hernández-Bartolomé, Ángel, et al.
Publicado: (2016)

Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma
por: Li, Yan, et al.
Publicado: (2020)

Comprehensive Analysis of VCAN Expression Profiles and Prognostic Values in HCC
por: Sun, Guangshun, et al.
Publicado: (2022)

Possible mechanisms associated with immune escape and apoptosis on anti-hepatocellular carcinoma effect of Mu Ji Fang granules
por: Zhang, Yi-Bing, et al.
Publicado: (2023)

VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2023)

Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication
por: Kunanopparat, Areerat, et al.
Publicado: (2018)

Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma
por: Kojima, Ryuta, et al.
Publicado: (2023)

Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer
por: Li, Ji, et al.
Publicado: (2018)

Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin
por: Zhao, Yong-Xun, et al.
Publicado: (2023)

Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy
por: Wei, Meng, et al.
Publicado: (2023)

Antioxidant axis Nrf2-keap1-ARE in inhibition of alcoholic liver fibrosis by IL-22
por: Ni, Ya-Hui, et al.
Publicado: (2017)

Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians
por: Youssef, Samar Samir, et al.
Publicado: (2022)

Integrated analysis of microRNA and mRNA expression profiles in HBx-expressing hepatic cells
por: Chen, Ruo-Chan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qvejpdjfu8vibpji6h69r6efp5